Prevention of obesity in antipsychotic, antidepressant and antiepileptic medication

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20080108602A1
SERIAL NO

11687954

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

O-(3-piperidino-2-hydroxypropyl)-nicotinic amidoxime or a pharmaceutically suitable acid addition salt thereof (BGP-15) can be used for the prevention or reduction of weight gain or obesity in a patient treated with an antipsychotic drug or an antidepressant drug or an antiepileptic drug.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
N-GENE RESEARCH LABORATORIES INC575 MADISON AVENUE 10TH FLOOR NEW YORK NY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Balogh, Gabor Szeged, HU 25 63
Bernath, Sandor Telki, HU 6 3
Brownstein, Mike Rockville, MD 2 0
Egri, Janos Budapest, HU 15 47
Kolonics, Attila Budapest, HU 10 15
Mandi, Jozsef Budapest, HU 1 0
Nagy, Peter Literati Budapest, HU 11 32
Roth, Jesse Whitestone, NY 8 21
Sumegi, Balazs Pecs, HU 13 60
Szilvassy, Zoltan Debrecen-Jozsa, HU 9 31
Takacs, Kalman Budapest, HU 17 107
Tory, Kalman Budapest, HU 10 24
Vigh, Laszlo Szeged, HU 15 35

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation